I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 24% ± 7% | |
| oligodendrocyte | 10 studies | 36% ± 11% | |
| glutamatergic neuron | 9 studies | 35% ± 23% | |
| fibroblast | 7 studies | 19% ± 4% | |
| ciliated cell | 7 studies | 25% ± 11% | |
| GABAergic neuron | 7 studies | 33% ± 19% | |
| natural killer cell | 6 studies | 21% ± 5% | |
| basal cell | 6 studies | 28% ± 10% | |
| epithelial cell | 6 studies | 36% ± 17% | |
| astrocyte | 6 studies | 28% ± 11% | |
| microglial cell | 5 studies | 22% ± 6% | |
| macrophage | 5 studies | 22% ± 5% | |
| B cell | 4 studies | 22% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 22% ± 6% | |
| adipocyte | 4 studies | 21% ± 4% | |
| type I pneumocyte | 4 studies | 20% ± 5% | |
| oligodendrocyte precursor cell | 4 studies | 31% ± 8% | |
| interneuron | 4 studies | 40% ± 21% | |
| CD4-positive, alpha-beta T cell | 3 studies | 16% ± 2% | |
| club cell | 3 studies | 20% ± 3% | |
| retinal cone cell | 3 studies | 24% ± 2% | |
| lymphocyte | 3 studies | 20% ± 1% | |
| T cell | 3 studies | 15% ± 0% | |
| endothelial cell of lymphatic vessel | 3 studies | 17% ± 2% | |
| transit amplifying cell | 3 studies | 26% ± 10% | |
| neuron | 3 studies | 32% ± 10% |
